Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping
Peter Gee(MaxCyte (United States)), Akitsu Hotta(Kyoto University)
Cited by 359
Related Papers
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
|Nature Communications|2021|277
Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein
|Stem Cell Reports|2021|51
Beneath the radar: immune-evasive cell sources for stroke therapy
|Trends in Molecular Medicine|2024|18